PI-VIEW
LIVE

Serial Number

97661016

Owner

Proteina Co., Ltd.

Attorney

Hun Joon Kim

Filing Date

Nov 3, 2022

Add to watchlist:

No watchlists yet
View on USPTO

PI-VIEW Trademark

Serial Number: 97661016 • Registration: 7963413

PI-VIEW is a trademark filed by Proteina Co., Ltd. on November 3, 2022. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Proteina Co., Ltd. (4 trademarks)

11, Digital-ro 33-gil,

Entity Type: 03

Trademark Details

Filing Date

November 3, 2022

Registration Date

September 30, 2025

Published for Opposition

February 25, 2025

Goods & Services

[Analyzers for analyzing immunological activity for medical purposes; Medical apparatus and instrument for diagnostic use, namely, for medical diagnostic testing in the fields of cell-based testing; Medical diagnostic apparatus for detecting cancer; Medical diagnostic apparatus for analyzing drug compounds; Immunoassay apparatus for detecting and analyzing biomarkers for medical diagnoses; Medical diagnostic apparatus for testing genomic materials, proteins, and cells relevant to diseases; Medical instruments for analyzing and identifying genomic materials, proteins, and cells; Medical diagnostic apparatus and instruments for detecting and analyzing diseases related to genetic abnormality, protein abnormality, abnormal expression of proteins, and abnormality in protein interaction signals; Medical imaging apparatus; Diagnostic measuring apparatus for medical use by analyzing genomic materials, proteins and cells; Apparatus for medical, clinical, and diagnostic uses by analyzing genomic materials, proteins, and cells related to genetic abnormality, protein abnormality, abnormal expression of proteins, and abnormality in protein interaction signals; Computer displays and computer monitors and controllers used in direct association with medical diagnosis apparatuses during the process of diagnosis of a condition, namely genetic abnormality, protein abnormality, abnormal expression of proteins, and abnormality in protein interaction signals in an individual; Immunochemical testing apparatus for analyzing genomic materials, proteins, and cells for medical use; Automatic analyzers for disease diagnosis through inspection of genomic materials, proteins, and bio-samples for medical purposes; Apparatus for testing genomic materials, proteins, and cells relevant to diseases for medical purposes; Apparatus for tumor diagnosis; Medical apparatus for testing genomic materials, proteins, and cells relevant to diseases, namely the cancer and inflammatory disease; Apparatus for analyzing images for medical use, namely, fluorescence imaging apparatus for medical purpose; Medical diagnostic apparatus for analyzing and measuring genomic materials, proteins, and bio-samples; In vitro medical diagnostic devices for molecularly characterizing diseases related to genetic abnormality, protein abnormality, abnormal expression of proteins, and abnormality in protein interaction signals] *Analyzers for analyzing immunological activity for medical purposes; Medical apparatus and instrument for diagnostic use, namely, for medical diagnostic testing in the fields of cell-based testing; Medical diagnostic apparatus for analyzing drug compounds; Immunoassay apparatus for detecting and analyzing biomarkers for medical diagnoses; Medical diagnostic apparatus for testing genomic materials, proteins, and cells relevant to diseases; Medical instruments for analyzing and identifying genomic materials, proteins, and cells; Medical diagnostic apparatus and instruments for detecting and analyzing diseases related to genetic abnormality, protein abnormality, abnormal expression of proteins, and abnormality in protein interaction signals; Diagnostic measuring apparatus for medical use by analyzing genomic materials, proteins and cells; Apparatus for medical, clinical, and diagnostic uses by analyzing genomic materials, proteins, and cells related to genetic abnormality, protein abnormality, abnormal expression of proteins, and abnormality in protein interaction signals; Computer displays and computer monitors and controllers used in direct association with medical diagnosis apparatuses during the process of diagnosis of a condition, namely genetic abnormality, protein abnormality, abnormal expression of proteins, and abnormality in protein interaction signals in an individual; Immunochemical testing apparatus for analyzing genomic materials, proteins, and cells for medical use; Automatic analyzers for disease diagnosis through inspection of genomic materials, proteins, and bio-samples for medical purposes; Apparatus for testing genomic materials, proteins, and cells relevant to diseases for medical purposes; Medical apparatus for testing genomic materials, proteins, and cells relevant to diseases, namely the cancer and inflammatory disease; Apparatus for analyzing images for medical use, namely, fluorescence imaging apparatus for medical purpose; Medical diagnostic apparatus for analyzing and measuring genomic materials, proteins, and bio-samples; In vitro medical diagnostic devices for molecularly characterizing diseases related to genetic abnormality, protein abnormality, abnormal expression of proteins, and abnormality in protein interaction signals; none of the foregoing for use in the mammography field or relating to the medical imaging of the breast*

[Biochip for research or scientific purposes; Biochip sensors for research or scientific purposes; Cell chip inspection devices, namely, bio-cell chips for research or scientific purposes; DNA chip; DNA analysis apparatus, namely, scientific apparatus for DNA purification and analysis; DNA sequencing devices, namely, scientific apparatus and instruments for sequencing DNA; Diagnostic apparatus for the detection of biomarkers for laboratory or research use; Protein analysis devices, namely, scientific apparatus and instruments for analyzing protein; Protein sequencing devices, namely, scientific apparatus and instruments for sequencing protein; Laboratory apparatus for analyzing biological pharmaceuticals; Scientific instruments for analyzing chemical and biological substances for the presence, absence, or quantity of target biologics and chemicals; Optical imaging apparatus and instruments for use in the study of proteins, peptides, DNA, aptamer, and RNA, not for medical purposes; Spectroscopes; Microscopes and parts thereof; Optical scanner; optical measurement components for biological industrial and research use; Computer storage devices, namely, high-speed storage subsystems for storage of optical images and measurement records; Biosensors, namely, sensors for the purpose of scientific and diagnostic use for detecting the presence of multiple molecular substances; Diagnostic apparatus for the detection of proteins, DNA, and cells, not for medical purpose; Downloadable images in the field of in vitro diagnostics, namely fluorescence images used for in vitro diagnostics; Analyzers for analyzing immunological activity for scientific purposes] *Biochip for research or scientific purposes; Biochip sensors for research or scientific purposes; Cell chip inspection devices, namely, bio-cell chips for research or scientific purposes; DNA chip; DNA analysis apparatus, namely, scientific apparatus for DNA purification and analysis; DNA sequencing devices, namely, scientific apparatus and instruments for sequencing DNA; Diagnostic apparatus for the detection of biomarkers for laboratory or research use; Protein analysis devices, namely, scientific apparatus and instruments for analyzing protein; Protein sequencing devices, namely, scientific apparatus and instruments for sequencing protein; Laboratory apparatus for analyzing biological pharmaceuticals; Scientific instruments for analyzing chemical and biological substances for the presence, absence, or quantity of target biologics and chemicals; Optical imaging apparatus and instruments for use in the study of proteins, peptides, DNA, aptamer, and RNA, not for medical purposes; Spectroscopes; Microscopes and parts thereof; Optical scanner; optical measurement components for biological industrial and research use; Computer storage devices, namely, high-speed storage subsystems for storage of optical images and measurement records; Biosensors, namely, sensors for the purpose of scientific and diagnostic use for detecting the presence of multiple molecular substances; Diagnostic apparatus for the detection of proteins, DNA, and cells, not for medical purpose; Downloadable images in the field of in vitro diagnostics, namely fluorescence images used for in vitro diagnostics; Analyzers for analyzing immunological activity for scientific purposes; none of the foregoing for use in the mammography field or relating to the medical imaging of the breast*

Filing History

POST REGISTRATION ACTION CORRECTION
May 14, 2026 XXXX
OTQR WITHDRAWAL FROM PUBLICATION
May 13, 2026 WDRL
AMENDMENT UNDER SECTION 7 - PROCESSED
Mar 16, 2026 A7OK
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 9, 2026 APRE
TEAS SECTION 7 REQUEST RECEIVED
Dec 9, 2025 ES7R
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 30, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 30, 2025 R.PR
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Sep 4, 2025 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Mar 26, 2025 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 25, 2025 NPUB
PUBLISHED FOR OPPOSITION
Feb 25, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 19, 2025 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 5, 2025 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 4, 2025 CNSA
ASSIGNED TO EXAMINER
Feb 3, 2025 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 7, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 7, 2025 CRFA
ASSIGNED TO LIE
Jan 6, 2025 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Nov 27, 2024 ERSI
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Nov 25, 2024 RCSC
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Oct 29, 2024 RCCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 1, 2024 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 1, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 1, 2024 COAR
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 14, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 14, 2023 GNSL
SUSPENSION LETTER WRITTEN
Dec 14, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 21, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 20, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 20, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 21, 2023 GNRN
NON-FINAL ACTION E-MAILED
Aug 21, 2023 GNRT
NON-FINAL ACTION WRITTEN
Aug 21, 2023 CNRT
ASSIGNED TO EXAMINER
Aug 14, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 21, 2022 NWOS
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Nov 15, 2022 TAEA
TEAS VOLUNTARY AMENDMENT RECEIVED
Nov 15, 2022 PARI
NEW APPLICATION ENTERED
Nov 7, 2022 NWAP